(19)
(11) EP 4 816 534 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24896556.8

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
A61K 31/713(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/713; C12N 15/113; C12N 2310/14
 
C-Sets:
  1. C12N 2310/321, C12N 2310/3521;
  2. C12N 2310/322, C12N 2310/3533;

(86) International application number:
PCT/CN2024/134773
(87) International publication number:
WO 2025/113470 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 WO PCT/CN2023/134234

(71) Applicant: Shanghai Argo Biopharmaceutical Co., Ltd.
Shanghai 201803 (CN)

(72) Inventors:
  • SHU, Dongxu
    Ningbo, Zhejiang 315100 (CN)
  • SHAO, Pengcheng Patrick
    Warrington Township Pennsylvania 18976 (US)
  • XIA, Shiwei
    Hangzhou, Zhejiang 311400 (CN)

(74) Representative: Elkington and Fife LLP 
Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN (TTR)